The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 11, 2020
Filed:
Jun. 21, 2017
Applicants:
Omrix Biopharmaceuticals Ltd., Rehovot, IL;
Ethicon, Inc., Somerville, NJ (US);
Inventors:
Yair Pilpel, Rehovot, IL;
Ashley Deanglis, Skillman, NJ (US);
Yuri Zherdev, Rehovot, IL;
Sivan Doron, Moshav Arugot, IL;
Anne Gorman, Hightstown, NJ (US);
Israel Nur, Moshav Timmorim, IL;
Assignees:
Omrix Biopharmaceuticals Ltd., Rehovot, IL;
Ethicon, Inc., Somerville, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/36 (2006.01); A61L 24/10 (2006.01); A61K 38/48 (2006.01); A61K 38/17 (2006.01); A61K 31/194 (2006.01); A61K 31/198 (2006.01); A61K 33/14 (2006.01); A61L 24/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4846 (2013.01); A61K 31/194 (2013.01); A61K 31/198 (2013.01); A61K 33/14 (2013.01); A61K 38/1767 (2013.01); A61K 38/36 (2013.01); A61K 38/363 (2013.01); A61K 38/4833 (2013.01); A61L 24/0015 (2013.01); A61L 24/106 (2013.01); C12Y 304/21005 (2013.01); C12Y 304/21006 (2013.01); C12Y 304/21022 (2013.01); A61L 2300/254 (2013.01); A61L 2300/418 (2013.01); C12Y 304/21021 (2013.01);
Abstract
Provided herein is a single component sealant formulation (e.g. in a liquid form), methods for its preparation, and use. The formulation includes fibrinogen; vitamin K-dependent clotting zymogens comprising at least Factor II (FII) and Factor X (FX).